JSPR vs. EVGO
JSPR (Jasper Therapeutics, Inc.) and EVGO (Evgo Inc) are both stocks. JSPR operates in Biotechnology (Healthcare), while EVGO operates in Specialty Retail (Consumer Cyclical). Over the past 3 years, JSPR returned -65.95%/yr vs -19.22%/yr for EVGO. At a 0.15 correlation, their price movements are largely independent.
Performance
JSPR vs. EVGO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JSPR achieves a -72.60% return, which is significantly lower than EVGO's -33.33% return.
JSPR
- 1D
- 10.71%
- 1M
- -44.46%
- YTD
- -72.60%
- 6M
- -73.74%
- 1Y
- -90.26%
- 3Y*
- -65.95%
- 5Y*
- —
- 10Y*
- —
EVGO
- 1D
- 0.00%
- 1M
- 3.19%
- YTD
- -33.33%
- 6M
- -38.41%
- 1Y
- -50.38%
- 3Y*
- -19.22%
- 5Y*
- -33.42%
- 10Y*
- —
JSPR vs. EVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
JSPR Jasper Therapeutics, Inc. | -72.60% | -91.44% | 170.98% | 63.39% | -93.85% | -37.90% |
EVGO Evgo Inc | -33.33% | -28.15% | 13.13% | -19.91% | -55.03% | 14.91% |
Correlation
The correlation between JSPR and EVGO is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Sep 24, 2021 | 0.15 |
Fundamentals
JSPR:
-$2.87
EVGO:
-$0.51
JSPR:
$0.00
EVGO:
$418.33M
JSPR:
-$290.00K
EVGO:
$84.41M
JSPR:
-$72.26M
EVGO:
-$36.37M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JSPR vs. EVGO — Risk / Return Rank
JSPR
EVGO
JSPR vs. EVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and Evgo Inc (EVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JSPR | EVGO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.03 | ||
| Sortino ratioReturn per unit of downside risk | -0.70 | ||
| Omega ratioGain probability vs. loss probability | 0.73 | 0.87 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | -0.76 | -0.21 |
| Martin ratioReturn relative to average drawdown | -1.23 | -1.26 | +0.03 |
Loading charts...
Drawdowns
JSPR vs. EVGO - Drawdown Comparison
The maximum JSPR drawdown since its inception was -99.72%, which is greater than EVGO's maximum drawdown of -92.48%. Use the drawdown chart below to compare losses from any high point for JSPR and EVGO.
Loading charts...
Drawdown Indicators
| JSPR | EVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.72% | -92.48% | -7.24% |
Max Drawdown (1Y)Largest decline over 1 year | -93.37% | -66.87% | -26.50% |
Max Drawdown (3Y)Largest decline over 3 years | -98.49% | -81.43% | -17.06% |
Max Drawdown (5Y)Largest decline over 5 years | — | -91.37% | — |
Current DrawdownCurrent decline from peak | -99.69% | -91.21% | -8.48% |
Average DrawdownAverage peak-to-trough decline | -88.49% | -70.15% | -18.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 73.29% | 39.88% | +33.41% |
Volatility
JSPR vs. EVGO - Volatility Comparison
Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 48.15% compared to Evgo Inc (EVGO) at 25.75%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than EVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JSPR | EVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 48.15% | 25.75% | +22.40% |
Volatility (6M)Calculated over the trailing 6-month period | 76.45% | 45.27% | +31.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 106.07% | 61.14% | +44.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 241.69% | 86.51% | +155.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 241.69% | 89.46% | +152.23% |
Dividends
JSPR vs. EVGO - Dividend Comparison
Neither JSPR nor EVGO has paid dividends to shareholders.
Financials
JSPR vs. EVGO - Financials Comparison
This section allows you to compare key financial metrics between Jasper Therapeutics, Inc. and Evgo Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
JSPR and EVGO have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JSPR has higher volatility (48.15%) compared to EVGO (25.75%). In terms of maximum drawdown, JSPR dropped -99.72% vs EVGO's -92.48%.
EVGO currently has the higher Sharpe Ratio (-0.83 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JSPR and EVGO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer